echocardiology.org

Tutorial

Aortic Regurgitation: Echocardiographic Assessment

Etiology, exam findings, and echocardiographic grading of aortic regurgitation, with severity criteria from the 2020 ACC/AHA and 2025 ESC/EACTS guidelines.

Published . Last reviewed .

Aortic regurgitation (AR), also called aortic insufficiency (AI), is diastolic backflow of blood from the aorta into the left ventricle through an incompletely competent aortic valve. It may present acutely — a surgical emergency in its severe form — or as a chronic, often slowly progressive process that the left ventricle compensates for over years before decompensating. This tutorial covers the clinical presentation and echocardiographic assessment of AR, with severity criteria drawn from the 2020 ACC/AHA and 2025 ESC/EACTS valvular heart disease guidelines.

Etiology

Acute AR is most often caused by:

  • Infective endocarditis, with leaflet destruction or perforation
  • Aortic dissection extending into the aortic root — proximal dissection rupturing into the pericardial space can also cause a rapidly accumulating pericardial effusion and cardiac tamponade, independent of the regurgitation itself
  • Trauma
  • Complication of catheter balloon valvuloplasty

Chronic AR is most often caused by:

  • Bicuspid aortic valve
  • Dilation of the aortic sinuses or ascending aorta (with or without an underlying valve abnormality)
  • Rheumatic valve disease
  • Aortic valve prolapse
  • Hypertension, typically producing mild regurgitation from valve sclerosis and aortic root dilation rather than primary leaflet disease
  • Connective tissue disease (e.g., Marfan syndrome)
  • A membranous ventricular septal defect, via the Venturi effect on an adjacent aortic cusp

In high-income countries, bicuspid valve disease and primary disease of the aortic root or ascending aorta are the leading causes of chronic severe AR; rheumatic disease remains a more common cause in lower- and middle-income countries.

Hemodynamic Consequences

Chronic AR imposes a combined volume and, over time, pressure load on the left ventricle. The ventricle compensates initially through eccentric hypertrophy and dilation, which can maintain a normal ejection fraction for years despite a large regurgitant volume. Left untreated, this compensation eventually fails, leading to reduced LV systolic function, congestive heart failure, and increased risk of adverse outcomes — which is why serial monitoring of LV size and function is central to management of asymptomatic chronic AR.

Acute severe AR does not allow time for this compensation. The regurgitant volume floods a normal-sized, non-compliant ventricle, causing a rapid rise in LV end-diastolic pressure that can precipitate pulmonary edema and cardiogenic shock even when the regurgitant volume itself is similar to a well-tolerated case of chronic severe AR.

Clinical Presentation

Symptoms (typically a late finding in chronic AR, reflecting decompensation):

  • Exertional dyspnea
  • Angina
  • Dizziness
  • Syncope

Auscultation:

  • A high-pitched, blowing, decrescendo diastolic murmur along the left sternal border — the hallmark finding
  • The Austin Flint murmur: a low-pitched, mid-diastolic rumble at the apex, heard in severe AR, thought to result from the regurgitant jet interfering with anterior mitral leaflet opening
  • A bisferiens (widely notched, double-peaked) arterial pulse may be palpable in significant AR

ECG: left ventricular hypertrophy and left atrial enlargement are common findings in chronic AR, reflecting volume overload — not diagnostic on their own, but supportive.

Chest X-ray: cardiomegaly (classically described as “cor bovinum” — an enlarged, boot-shaped cardiac silhouette in severe chronic AR) and a dilated aortic root.

Echocardiographic Assessment

2D and M-Mode Findings

  • Direct visualization of the anatomic basis for AR where present — a flail cusp, prolapse, perforation, or ascending aortic aneurysm
  • Incomplete aortic valve coaptation (a visible gap between cusps) on the parasternal short-axis view
  • LV volume overload pattern: a dilated, hyperdynamic left ventricle
  • Reverse doming of the anterior mitral leaflet, seen in severe AR
  • On M-mode: diastolic fluttering of the anterior mitral leaflet, chordae, or interventricular septum from the regurgitant jet striking these structures; diastolic flutter of the aortic valve itself
  • Signs of acute severe AR: premature closure of the mitral valve (the M-mode “C point” occurring before the QRS) and premature opening of the aortic valve, both reflecting a rapidly rising LV diastolic pressure that equilibrates with aortic diastolic pressure before the next systole

Doppler and Color Flow Assessment

Guideline-based assessment of AR severity is integrative — no single parameter is used in isolation. The criteria below, drawn from the 2025 ESC/EACTS guideline’s framework, are grouped the same way:

Qualitative:

  • Abnormal valve morphology, flail cusp, or a large coaptation defect on 2D imaging

Semi-quantitative (color and spectral Doppler):

  • Vena contracta width — the narrowest width of the regurgitant jet as it passes through the valve orifice, measured in the parasternal long-axis view. A vena contracta >0.6 cm (>6 mm) supports severe AR.
  • Jet width relative to LVOT diameter, measured just below the valve — a large, central jet occupying ≥65% of the LVOT diameter supports severe AR. (This parameter is also sometimes recorded as jet height/LVOT height in practice — the two describe the same measurement.)
  • Pressure half-time (PHT) of the regurgitant CW Doppler signal — the time for the peak diastolic gradient to fall by half. A PHT < 200 ms supports severe chronic AR, since it reflects rapid equalization of aortic and LV diastolic pressures.
  • Holodiastolic flow reversal in the descending aorta, with an end-diastolic velocity ≥20 cm/s, is a specific finding supporting at least moderate-to-severe AR. This finding is not AR-specific, though — a patent ductus arteriosus produces the same holodiastolic reversal from ductal runoff, and the two can genuinely coexist in the same adult patient; see Patent Ductus Arteriosus for how the two are distinguished.

Quantitative (volumetric):

  • Effective regurgitant orifice area (EROA) ≥0.30 cm² (≥30 mm²) supports severe AR
  • Regurgitant volume (RVol) ≥60 mL/beat supports severe AR
  • Regurgitant fraction (RF) — the cutoff differs by modality: >50% by echocardiography, but >40% by cardiac MRI, per the 2025 ESC/EACTS guideline. This distinction matters when comparing an echo report to a CMR report for the same patient.

Guideline-Based Severity Grading

The table below summarizes the 2020 ACC/AHA staging criteria for chronic AR. The 2025 ESC/EACTS guideline uses largely consistent cutoffs for its “severe AR” criteria (vena contracta, jet width, PHT, holodiastolic reversal, EROA, and regurgitant volume all align closely with the values below; see the RF-by-modality note above for the one point where the two guidelines’ presentation differs).

ParameterMild ARModerate ARSevere AR
Jet width / LVOT diameter< 25%25–64%≥65%
Vena contracta< 0.3 cm0.3–0.6 cm>0.6 cm
Regurgitant volume< 30 mL/beat30–59 mL/beat≥60 mL/beat
Regurgitant fraction (echo)< 30%30–49%≥50%
Effective regurgitant orifice area< 0.10 cm²0.10–0.29 cm²≥0.30 cm²

Beyond grading severity itself, the ACC/AHA staging system (Stages A–D) also incorporates LV size and function and symptom status, since these — not the regurgitant severity alone — ultimately guide the timing of intervention in chronic AR.

A Note on Older Grading Schemes

Older teaching materials and some angiography- or Doppler-mapping-based echo reports still use a four-tier 1+ (mild) to 4+ (severe) grading scale, sometimes with additional semi-quantitative parameters such as color-jet-area-to-LVOT-area ratio. These schemes generally still identify the same patients at the extremes (very mild versus very severe AR), and the outer bounds of the older jet-width-based 1+/4+ cutoffs match the current mild/severe thresholds above. However, they aren’t the primary grading framework in the current ACC/AHA or ESC/EACTS guidelines, and parameters like color jet area are especially flow- and technique-dependent and are not emphasized in either document. When in doubt, favor the vena contracta, PHT, holodiastolic flow reversal, and quantitative (RVol/RF/EROA) parameters above.

Acute AR: A Surgical Emergency

Acute severe AR — most often from infective endocarditis or aortic dissection — requires urgent recognition. Echocardiography (transthoracic or transesophageal) is essential to confirm the diagnosis, assess severity and etiology, evaluate the aortic root, and assess LV size and function. Two findings reflect the rapid rise in LV diastolic pressure characteristic of acute severe AR:

  • A short deceleration time on the aortic regurgitant Doppler signal, with a PHT < 300 ms
  • Premature (early) closure of the mitral valve, seen on M-mode as the mitral “C point” occurring before the QRS complex

Medical therapy to reduce afterload may provide temporary stabilization, but surgery should not be delayed — especially with hypotension, pulmonary edema, or evidence of low cardiac output. Intra-aortic balloon counterpulsation is contraindicated in acute severe AR, since it increases diastolic aortic pressure and would worsen the regurgitant volume. Beta-blockers, often reflexively considered in a tachycardic patient, should be used very cautiously (if at all) outside the specific context of aortic dissection, since blunting the compensatory tachycardia can precipitate a further drop in blood pressure.

Practical Pearls

  • Assess AR severity using multiple parameters together, not any single measurement in isolation — this is the explicit approach recommended by both current guidelines.
  • Always consider the patient’s blood pressure at the time of the study: elevated afterload can overestimate regurgitant volume.
  • In chronic AR, the trend in LV size and function over serial studies is often more clinically useful than any single severity grade.
  • Don’t conflate the two PHT cutoffs above — context (acute presentation vs. routine chronic AR grading) determines which applies.
  • The same “multiple parameters together” principle applies to a prosthetic aortic valve, where AR quantitation is further complicated by combined valvular and paravalvular jets, and where the small, low-momentum “washing jets” of a normally functioning mechanical valve should not be mistaken for pathologic regurgitation.

References

  1. 1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):e25-e197.
  2. 2. Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46(44):4635-4736.
  3. 3. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):303-371.
  4. 4. Otto CM. Textbook of Clinical Echocardiography. 6th ed. Philadelphia, PA: Elsevier; 2018.